Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

In the closing of the recent trading day, Tilray Brands, Inc. (TLRY) stood at $1.74, denoting no change from the preceding trading day.

Tilray Brands, Inc. (TLRY) Flat As Market Sinks: What You Should Know

Carnival

NIKE

Constellation Brands

American stocks performed great this week, thanks to the recent decision by the Federal Reserve to cut interest rates and the robust stimulus provided by Chinese authorities. The Dow Jones rose for three consecutive weeks, reaching a record high of $42,310.

Stocks to watch next week: Tilray, Nike, Carnival, Constellation Brands

PORTLAND, Ore., Sept. 26, 2024 (GLOBE NEWSWIRE) -- The Shock Top Company, a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), is excited to introduce its latest innovation: Shock Top LiiT Hard Iced Tea.

Shock Top's Bold New Hard Iced LiiT Tea is Here

Tilray Brands, Inc. (TLRY) reachead $1.72 at the closing of the latest trading day, reflecting a +1.78% change compared to its last close.

Tilray Brands, Inc. (TLRY) Exceeds Market Returns: Some Facts to Consider

Aurora Cannabis

Canopy Growth

The Canadian cannabis market remains a focal point for investors this week, especially with companies expanding into the U.S. market. Recently, the U.S. cannabis industry has shown remarkable growth, with sales projected to reach $45 billion by 2025. This expansion offers Canadian companies a gateway to a larger consumer base. The increasing push for legalization in the U.S. is also a significant factor. States are continuously passing legislation to legalize cannabis for recreational and medicinal use. Therefore, investors watch how Canadian stocks position themselves for potential U.S. market entry.

Canadian Cannabis Stocks Set to Soar Right Now

PORTLAND, Ore., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Today, The Shock Top Company, a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), proudly announces a new partnership with Mizzou Athletics as the official craft beer sponsor of the University of Missouri Tigers.

Shock Top Announces its Official Craft Beer Sponsorship of University of Missouri Athletics

The latest trading day saw Tilray Brands, Inc. (TLRY) settling at $1.80, representing a -0.55% change from its previous close.

Tilray Brands, Inc. (TLRY) Sees a More Significant Dip Than Broader Market: Some Facts to Know

In the most recent trading session, Tilray Brands, Inc. (TLRY) closed at $1.81, indicating a +0.56% shift from the previous trading day.

Tilray Brands, Inc. (TLRY) Laps the Stock Market: Here's Why

TLRY acquires the Atwater Brewery, the last in the series of recent acquisitions from Molson Coors. The buyout is likely to expand TLRY's craft beer portfolio.

What's Next for Tilray After Acquiring Molson Coors' Atwater Brewery?

Atwater Brewery from Molson Coors joins Tilray Brands' beverage portfolio which includes leading craft beer, spirits, and non-alcohol beverage brands.

Tilray Brands Completes Acquisition of Atwater Brewery From Molson Coors Beverage Company

Cronos Group

SNDL Inc.

Over the last several days some marijuana stocks have begun to pick up in momentum. There have been several attempts to show good faith in the legalization efforts for cannabis markets across the USA. Recently Trump has shown his support for legal cannabis in Florida under the right conditions. From this news, more people began to speculate that Trump's support can mean big things for legal cannabis. In addition to fueling more profitable trading in the hopes of better reform measures.

3 Marijuana Stocks To Watch On September 11th

The latest trading day saw Tilray Brands, Inc. (TLRY) settling at $1.70, representing no change from its previous close.

Tilray Brands, Inc. (TLRY) Flat As Market Gains: What You Should Know

TLRY stock got a lift after Donald Trump said he supported lowering the classification of the drug. Is now the time to buy the cannabis stock?

Is Tilray A Buy Following Trump Social Media Post?

Shares of Canopy Growth (CGC), Tilray Brands (TLRY), and other cannabis providers surged in intraday trading Monday after former President Donald Trump signaled his support for reducing restrictions on marijuana use.

Cannabis Stocks Get Boost as Trump Backs Easing Restrictions

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Amplify Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

Trulieve Cannabis Corp.

GOP presidential nominee Donald Trump supports Schedule III classification for cannabis, which has already been proposed by the Biden administration.

Cannabis stocks rally after Trump supports moving drug to less restrictive category

Tilray Brands (NASDAQ: TLRY) stock price has crashed hard this year, continuing a downtrend that started in 2018 when it peaked at $300. It has plunged to $1.62, bringing its market cap to over $1.37 billion.

Tilray Brands stock sits at a make-or-break price: now what?

LISBON, Portugal, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, today announced a new scientific publication supported by Tilray Medical titled, Treatment in Pain Management and Other Fibromyalgia-Associated Symptoms: A Case Series (TOMAS) .  The study examines the real-world impact of cannabinoid treatments on patients with fibromyalgia (FM) under the guidance of healthcare providers.

Tilray Medical Supports Scientific Study on Fibromyalgia With Positive Outcomes: Effectiveness of Cannabinoids Treatment in Pain Management and Other Fibromyalgia-Associated Symptoms

The cannabis market is abuzz following former President Donald Trump's recent comments supporting cannabis legalization in Florida.

Trump's Marijuana Support Could Ignite Stock Surge – Are You Positioned To Benefit?

In the closing of the recent trading day, Tilray Brands, Inc. (TLRY) stood at $1.66, denoting a -1.19% change from the preceding trading day.

Here's Why Tilray Brands, Inc. (TLRY) Fell More Than Broader Market

Tilray Brands concludes the acquisition of three craft breweries and related brands from Molson Coors, expanding its position in the U.S. craft beer market.

TLRY Grows Craft Beer Portfolio by Acquiring Molson Coors Brands

NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”, “our”, “we” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company, has successfully completed the previously announced acquisition of craft breweries Hop Valley Brewing Company, Terrapin Beer Co., and Revolver Brewing, from Molson Coors Beverage Company (“Molson Coors”) (NYSE: TAP).

Tilray Brands Completes Acquisition of Craft Beer Brands and Breweries from Molson Coors Beverage Company

Village Farms International

Investors looking to capitalize on the growing cannabis market should watch top Canadian marijuana stocks this week. With the US cannabis industry projected to reach $41 billion by 2025, many Canadian companies are expanding their presence across the border. This expansion is driven by increasing legalization efforts and growing consumer demand. For example, recent news highlights the potential for federal legalization in the US, which could open up significant opportunities for Canadian companies. Investors should utilize technical analysis and proper risk management strategies to navigate this dynamic market. Analyzing price trends, volume, and support levels can provide valuable insights into potential stock movements.

Best Canadian Cannabis Stocks to Watch in September

Alliance Global Partners Aaron Grey sees Donald Trump's weekend statement on cannabis as a step forward.

Cannabis stocks rally as analyst hails pot as an ‘increasingly bipartisan' issue

Tilray Brands, Inc. (TLRY) closed the most recent trading day at $1.70, making no change from the previous trading session.

Tilray Brands, Inc. (TLRY) Trades Flat On The Day: What You Should Know

Cannabis stocks have crashed hard this year as concerns about the industry continued. The AdvisorShares Pure US Cannabis ETF (MSOS) stock has plunged by almost 14% this year and is down by over 46% from its highest point this year.

News for Tilray Brands Stock (TLRY)